| Indicators | Browse All

Azitra, Inc. (AZTR)

Healthcare | Biotechnology | Branford, United States | NYSE American
0.07 USD

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 6:53 a.m. EDT

The immediate outlook is severely clouded by a catastrophic multi-year price collapse, which serves as the market's definitive verdict on the company's deteriorating prospects. Despite a recent spike driven by a CEO-backed private placement and insider buying, the stock has lost nearly 99.7% of its value over the last two years, with the most recent annual period seeing another massive drop of roughly 79%. This relentless downward trajectory, compounded by negative earnings, negative free cash flow, and a forward P/E that indicates no expected profitability, suggests the business fundamentals are failing rather than merely undervalued. The recent price jump appears to be a liquidity event or a desperate attempt to raise capital rather than a sign of operational recovery, especially given the heavy discount to the analyst mean target which implies significant future growth that the current financials do not support. With no dividend history to speak of and a balance sheet showing significant cash burn relative to its tiny market cap, there is no margin of safety here; the price action confirms that investors are fleeing the asset. The statistical forecast model offers no help, citing very low confidence due to the extreme volatility and noise inherent in such a distressed trading environment. Consequently, the short-term view remains bearish as the stock struggles to find a floor, and the long-term view is even more dire, as the structural damage to the equity value is profound.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.175742
MSTL0.183230
AutoARIMA0.446793
AutoTheta0.461442

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 30%
H-stat 19.15
Ljung-Box p 0.000
Jarque-Bera p 0.068
Excess Kurtosis -1.66
Attribute Value
Sector Healthcare
Debt to Equity Ratio 5.591
Market Cap 4,333,168
Forward P/E -0.14
Beta -1.04
Previous Name Azitra Inc
Website https://azitrainc.com

Info Dump

Attribute Value
52 Week Change -0.898017
Address1 21 Business Park Drive
All Time High 1,036.0
All Time Low 0.052
Ask 0.0739
Ask Size 500
Average Daily Volume10 Day 794,140
Average Daily Volume3 Month 1,676,423
Average Volume 1,676,423
Average Volume10Days 794,140
Beta -1.04
Bid 0.07
Bid Size 200
Book Value 0.121
City Branford
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.0715
Current Ratio 4.863
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.1213
Day Low 0.0518
Debt To Equity 5.591
Display Name Azitra
Dividend Yield 0.0
Ebitda -12,201,906
Ebitda Margins 0.0
Enterprise To Ebitda 0.163
Enterprise Value -1,984,589
Eps Forward -0.52
Eps Trailing Twelve Months -0.28
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.15178
Fifty Day Average Change -0.08027999
Fifty Day Average Change Percent -0.5289234
Fifty Two Week Change Percent -89.8017
Fifty Two Week High 1.09
Fifty Two Week High Change -1.0185001
Fifty Two Week High Change Percent -0.9344037
Fifty Two Week Low 0.0518
Fifty Two Week Low Change 0.019700002
Fifty Two Week Low Change Percent 0.3803089
Fifty Two Week Range 0.0518 - 1.09
Financial Currency USD
First Trade Date Milliseconds 1,686,922,200,000
Float Shares 51,252,585
Forward Eps -0.52
Forward P E -0.13750002
Free Cashflow -7,242,045
Full Exchange Name NYSE American
Full Time Employees 13
Fullday Change -0.046099998
Fullday Change Percent -39.200676
Fullday Price 0.0715
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.07593
Held Percent Institutions 0.32041
Implied Shares Outstanding 60,603,742
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,755,734,400
Last Split Factor 15:100
Long Business Summary Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
Long Name Azitra, Inc.
Market us_market
Market Cap 4,333,168
Market State REGULAR
Max Age 86,400
Message Board Id finmb_404021170
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-14
Net Income To Common -12,272,932
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 10,029,919
Number Of Analyst Opinions 2
Open 0.1207
Operating Cashflow -11,105,767
Operating Margins 0.0
Payout Ratio 0.0
Phone 203 646 6446
Prev Name Azitra Inc
Previous Close 0.0715
Price Hint 4
Price To Book 0.5909091
Profit Margins 0.0
Quick Ratio 4.49
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 0.1213
Regular Market Day Low 0.0518
Regular Market Day Range 0.0518 - 0.1213
Regular Market Open 0.1207
Regular Market Previous Close 0.0715
Regular Market Price 0.0715
Regular Market Time 1,791,985,562
Regular Market Volume 2,670,553
Return On Assets -1.19912
Return On Equity -2.56667
Sand P52 Week Change 0.17004645
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 60,603,742
Shares Percent Shares Out 0.004
Shares Short 240,809
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 1,368,917
Short Name Azitra Inc
Short Percent Of Float 0.0044
Short Ratio 0.34
Source Interval 15
State CT
Symbol AZTR
Target High Price 1.0
Target Low Price 0.34
Target Mean Price 0.67
Target Median Price 0.67
Total Cash 6,727,810
Total Cash Per Share 0.111
Total Debt 410,053
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.28
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 0.19632
Two Hundred Day Average Change -0.124819994
Two Hundred Day Average Change Percent -0.6357987
Type Disp Equity
Volume 2,670,553
Website https://azitrainc.com
Zip 6,405